Announce Date | 05/06/2025 |
EPS Normalized Actual | $0.53 (Beat by $0.05) |
EPS GAAP Actual | $0.53 (Beat by $0.05) |
Revenue Actual | $3.491B |
Revenue Surprise | Beat by $3491M |
Announce Date | 09/26/2025 (Pre-Market) |
EPS Normalized Estimate | $0.58 |
EPS GAAP Estimate | $0.58 |
Revenue Estimate | $3.635433333B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Sep 2029 | 3.6 | 6.71 | 3.56435 | 3.64119 | 1 |
Sep 2028 | 3.3 | 7.32 | 3.26732 | 3.33776 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.189 | 0.189 | 3.491B | 59.18% | 3491M |
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 3.416B | 60.1% | 3416M |
FQ4 2022 (Dec 2022) | 0 | 0 | 1.274B | 100% | 1274M |
FQ1 2023 (Mar 2023) | 0 | 0 | 1.391B | 100% | 1391M |
FQ2 2023 (Jun 2023) | 0 | 0 | 1.401B | 100% | 1401M |
FQ3 2023 (Sep 2023) | 0 | 0 | 1.47B | 100% | 1470M |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 1.363B | 6.53% | 1363M |
FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 1.425B | 2.39% | 1425M |
FQ4 Announce Date
09/26/2025 (Pre-Market)
Consensus EPS Estimates
0.58
Consensus Revenue Estimates
3.635433333B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.76 | -- | 0.7535 | 0.76829 | 5 |
FQ2 2027 (Jun 2027) | 0.67 | -- | 0.66427 | 0.67731 | 2 |
FQ1 2027 (Mar 2027) | 0.695 | -- | 0.68906 | 0.70258 | 2 |
FQ4 2026 (Dec 2026) | 0.67 | -- | 0.64719 | 0.68188 | 1 |
FQ3 2026 (Sep 2026) | 0.65333 | -- | 0.64451 | 0.66009 | 1 |
FQ2 2026 (Jun 2026) | 0.61 | -- | 0.60177 | 0.61631 | 1 |
FQ1 2026 (Mar 2026) | 0.56 | 66.25 | 0.55244 | 0.56579 | 1 |
FQ4 2025 (Dec 2025) | 0.53333 | 47.5 | 0.52613 | 0.53885 | 1 |
FQ3 2025 (Sep 2025) | 0.58 | -- | 0.57217 | 0.586 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.86B | -- | 3.83B | 3.89B | 6 |
FQ2 2027 (Jun 2027) | 3.76B | -- | 3.74B | 3.79B | 3 |
FQ1 2027 (Mar 2027) | 3.75B | -- | 3.73B | 3.79B | 3 |
FQ4 2026 (Dec 2026) | 3.68B | -- | 3.58B | 3.73B | 1 |
FQ3 2026 (Sep 2026) | 3.81B | -- | 3.77B | 3.84B | 1 |
FQ2 2026 (Jun 2026) | 3.71B | -- | 3.67B | 3.74B | 1 |
FQ1 2026 (Mar 2026) | 3.59B | 2.81 | 3.55B | 3.62B | 1 |
FQ4 2025 (Dec 2025) | 3.52B | 3.01 | 3.49B | 3.55B | 1 |
FQ3 2025 (Sep 2025) | 3.64B | -16.68 | 3.6B | 3.66B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
0
EPS # of in-lines
4
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.189 | 0.189 | 100% | |
FQ4 2024 (Dec 2024) | 0.28 | 0.28 | 100% | |
FQ4 2022 (Dec 2022) | 0 | 0 | NAN% | |
FQ1 2023 (Mar 2023) | 0 | 0 | NAN% | |
FQ2 2023 (Jun 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0.72 | 0.72 | 100% | |
FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $3.49B | $3491M | 100% |
FQ4 2024 (Dec 2024) | $0B | $3.42B | $3416M | 100% |
FQ4 2022 (Dec 2022) | $0B | $1.27B | $1274M | 100% |
FQ1 2023 (Mar 2023) | $0B | $1.39B | $1391M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.4B | $1401M | 100% |
FQ3 2023 (Sep 2023) | $0B | $1.47B | $1470M | 100% |
FQ4 2023 (Dec 2023) | $0B | $1.36B | $1363M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.43B | $1425M | 100% |